EPCA – The excellent paper in cardiovascular research award.
The ERA-CVD partner countries are issuing the 2nd Excellent Paper in Cardiovascular research Award (EPCA) to recognize the most remarkable and outstanding scientific publications by young researchers in the field of cardiovascular research. First authors of candidate publications published between January 1st, 2018 and December 31st, 2018 from CVD partner countries are eligible to apply. The deadline for proposal submission is March 1st 2019.
An award will be presented to the best proposal. The winner will be invited as a special ERA-CVD Young Investigator guest to the ESC Congress 2019, 31 Aug - 04 Sep 2019 in Paris*, where the award ceremony will take place. The travel costs and accommodation during the congress will be covered by ERA-CVD.
Participating funding agencies: All ERA-CVD partner countries
ERA CVD announces the launch of the first EXCELLENT PAPER IN CARDIOVASCULAR RESEARCH AWARD: The award will emphasize the importance of CVD and is designed as a form of support and encouragement for young researchers at the early stage of their career. The ERA CVD partner organizations issue this award to recognize the most remarkable and outstanding scientific publications by young researchers in the field of cardiovascular research.
From right to left: Dr. Irit Allon work package leader of the activities for early career scientists, the awardee Dr. Shashi Kumar Gupta and Dr. Wolfgang Ballensiefen ERA-CVD coordinator.
EPCA is given to a young researcher for an excellent publication in the field of cardiovascular research.
The winner of the first EPCA call is Dr. Shashi Kumar Gupta from the Institute of Molecular and Translational Therapeutic Strategies in Hannover Medical School, Germany. The winning paper Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression was published in “Circulation Research” on November 2017.
The EPCA ceremony took place at the ESC congress in Munich on August 27 2018.